UB Paderborn / Katalog / Suche / in CDI

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015-05, Vol.11 (1), p.68

2015

Link zum Volltext

Verfügbarkeit prüfen

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial

Europace (London, England), 2008-05, Vol.10 (5), p.528-535

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of Mitral Regurgitation on the Outcome of Patients Treated with CRT-D: Data from the InSync ICD Italian Registry

Pacing and clinical electrophysiology, 2012-02, Vol.35 (2), p.146-154

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry

European heart journal, 2009-09, Vol.30 (18), p.2275-2283

2009

Link zum Volltext

Verfügbarkeit prüfen

Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure

European journal of heart failure, 2008-11, Vol.10 (11), p.1073-1079

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistent Atrial Fibrillation Worsens Heart Rate Variability, Activity and Heart Rate, as Shown by a Continuous Monitoring by Implantable Biventricular Pacemakers in Heart Failure Patients

Journal of cardiovascular electrophysiology, 2008-07, Vol.19 (7), p.693-701

2008

Link zum Volltext

Verfügbarkeit prüfen

Follow-Up of CRT-ICD: Implications for the Use of Remote Follow-Up Systems. Data from the InSync ICD Italian Registry

Pacing and clinical electrophysiology, 2008-01, Vol.31 (1), p.38-46

2008

Link zum Volltext

Verfügbarkeit prüfen

Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial

Europace (London, England), 2009-05, Vol.11 (5), p.587-593

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease fragmin in unstable coronary artery disease study (FRIC)

Circulation (New York, N.Y.), 1997-07, Vol.96 (1), p.61-68

1997

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Effectiveness of Sirolimus-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Patients at High Risk for Coronary Restenosis or Clinical Adverse Events

The American journal of cardiology, 2005-06, Vol.95 (12), p.1409-1414

2005

Link zum Volltext

Verfügbarkeit prüfen

Reduction in time delays in administering thrombolytic therapy in acute myocardial infarction

Heart (British Cardiac Society), 1999-06, Vol.81 (6), p.674-675

1999

Link zum Volltext

Verfügbarkeit prüfen

The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population

Cardiology, 2008-01, Vol.110 (4), p.271-282

2008

Link zum Volltext

Verfügbarkeit prüfen

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty : results of the randomized, double-blind STARC study

Circulation (New York, N.Y.), 1994-12, Vol.90 (6), p.2710-2715

1994

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy

The Journal of invasive cardiology, 1994-01, Vol.6 (1), p.1

1994

Link zum Volltext

Verfügbarkeit prüfen

Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting

Catheterization and cardiovascular interventions, 2005-03, Vol.64 (3), p.375-382

2005

Link zum Volltext

Verfügbarkeit prüfen

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica

Circulation (New York, N.Y.), 1994-12, Vol.90 (6), p.2710-2715

1994

Link zum Volltext

Verfügbarkeit prüfen

MEDICAL SCIENCE: GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

The Lancet (British edition), 1990-07, Vol.336 (8707), p.65-71

GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAVVIVENZA NELL'INFARTO MIOCARDICO

1990

Link zum Volltext

Verfügbarkeit prüfen

A15-2 Cerebral vasoconstriction in neurally-mediated syncope: Relationship with type of head-up tilt test positive response

Europace (London, England), 2003-12, Vol.4 (Supplement_2), p.B22-B23

2003

Link zum Volltext

Verfügbarkeit prüfen

Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial

Minerva cardioangiologica, 2007-06, Vol.55 (3), p.281

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Bosentan fosters microvascular de-remodelling in systemic sclerosis

A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: The Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Comparison of Effectiveness and Safety of Sirolimus -Eluting Stents Versus Bare-Metal Stents in Patients With Diabetes Mellitus (from the Italian Multicenter Randomized DESSERT Study)

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial

Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry

Impact of Mitral Regurgitation on the Outcome of Patients Treated with CRT-D: Data from the InSync ICD Italian Registry

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry

Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure

Persistent Atrial Fibrillation Worsens Heart Rate Variability, Activity and Heart Rate, as Shown by a Continuous Monitoring by Implantable Biventricular Pacemakers in Heart Failure Patients

Follow-Up of CRT-ICD: Implications for the Use of Remote Follow-Up Systems. Data from the InSync ICD Italian Registry

Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease fragmin in unstable coronary artery disease study (FRIC)

Comparison of Effectiveness of Sirolimus-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Patients at High Risk for Coronary Restenosis or Clinical Adverse Events

Reduction in time delays in administering thrombolytic therapy in acute myocardial infarction

The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty : results of the randomized, double-blind STARC study

Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy

Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica

MEDICAL SCIENCE: GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

A15-2 Cerebral vasoconstriction in neurally-mediated syncope: Relationship with type of head-up tilt test positive response

Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial

Suchergebnisse filtern